Literature DB >> 19426741

Binding of 2'-amino-2'-deoxycytidine-5'-triphosphate to norovirus polymerase induces rearrangement of the active site.

Dmitry F Zamyatkin1, Francisco Parra, Angeles Machín, Pawel Grochulski, Kenneth K-S Ng.   

Abstract

Crystal structures of a genogroup II.4 human norovirus polymerase bound to an RNA primer-template duplex and the substrate analogue 2'-amino-2'-deoxycytidine-5'-triphosphate have been determined to 1.8 A resolution. The alteration of the substrate-binding site that is required to accommodate the 2'-amino group leads to a rearrangement of the polymerase active site and a disruption of the coordination shells of the active-site metal ions. The mode of binding seen for 2'-amino-2'-deoxycytidine-5'-triphosphate suggests a novel molecular mechanism of inhibition that may be exploited for the design of inhibitors targeting viral RNA polymerases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19426741     DOI: 10.1016/j.jmb.2009.04.069

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  28 in total

1.  Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase.

Authors:  Peng Gong; Olve B Peersen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-10       Impact factor: 11.205

2.  Norovirus RNA-dependent RNA polymerase is phosphorylated by an important survival kinase, Akt.

Authors:  John-Sebastian Eden; Laura J Sharpe; Peter A White; Andrew J Brown
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

3.  Motif D of viral RNA-dependent RNA polymerases determines efficiency and fidelity of nucleotide addition.

Authors:  Xiaorong Yang; Eric D Smidansky; Kenneth R Maksimchuk; David Lum; Jesse L Welch; Jamie J Arnold; Craig E Cameron; David D Boehr
Journal:  Structure       Date:  2012-07-19       Impact factor: 5.006

Review 4.  Current tools for norovirus drug discovery.

Authors:  Sahani Weerasekara; Allan M Prior; Duy H Hua
Journal:  Expert Opin Drug Discov       Date:  2016-05-02       Impact factor: 6.098

5.  Biochemical Evaluation of the Inhibition Properties of Favipiravir and 2'-C-Methyl-Cytidine Triphosphates against Human and Mouse Norovirus RNA Polymerases.

Authors:  Zhinan Jin; Kathryn Tucker; Xiaoyan Lin; C Cheng Kao; Ken Shaw; Hua Tan; Julian Symons; Ishani Behera; Vivek K Rajwanshi; Natalia Dyatkina; Guangyi Wang; Leo Beigelman; Jerome Deval
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

6.  Attenuation of Foot-and-Mouth Disease Virus by Engineered Viral Polymerase Fidelity.

Authors:  Devendra K Rai; Fayna Diaz-San Segundo; Grace Campagnola; Anna Keith; Elizabeth A Schafer; Anna Kloc; Teresa de Los Santos; Olve Peersen; Elizabeth Rieder
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

Review 7.  Treatment of norovirus infections: moving antivirals from the bench to the bedside.

Authors:  Stuart S Kaufman; Kim Y Green; Brent E Korba
Journal:  Antiviral Res       Date:  2014-02-25       Impact factor: 5.970

8.  Substrate recognition by norovirus polymerase: microsecond molecular dynamics study.

Authors:  Kamil Maláč; Ivan Barvík
Journal:  J Comput Aided Mol Des       Date:  2013-04-26       Impact factor: 3.686

9.  Antiviral activity of nucleoside analogues against norovirus.

Authors:  Verónica P Costantini; Tony Whitaker; Leslie Barclay; David Lee; Tamara R McBrayer; Raymond F Schinazi; Jan Vinjé
Journal:  Antivir Ther       Date:  2012-08-14

10.  Vaccine-derived mutation in motif D of poliovirus RNA-dependent RNA polymerase lowers nucleotide incorporation fidelity.

Authors:  Xinran Liu; Xiaorong Yang; Cheri A Lee; Ibrahim M Moustafa; Eric D Smidansky; David Lum; Jamie J Arnold; Craig E Cameron; David D Boehr
Journal:  J Biol Chem       Date:  2013-09-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.